NEW YORK, Dec. 18, 2013 /PRNewswire/ -- Levi &
Korsinsky notifies investors of NuPathe Inc. ("NuPathe") (Nasdaq:
PATH) of possible breaches of fiduciary duty and other violations
of state law in connection with the sale of the Company to Endo
Health Solutions (Nasdaq: ENDP).
(Logo:
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)
Click here to learn more about the action
http://zlk.9nl.com/nupathe-path/, or call: 877-363-5972.
There is no cost or obligation to you.
Under the terms of the transaction, NuPathe shareholders will
receive $2.85 for each share of
NuPathe stock they own, as well as rights to receive additional
payments up to $3.15 per share if
NuPathe's treatment ZECUITY reaches specified net sales over time.
The transaction has a total approximate value of $105 million. The investigation concerns whether
the NuPathe Board of Directors breached their fiduciary duties to
stockholders by failing to adequately shop the Company before
agreeing to enter into this transaction, and whether Endo Health
Solutions is underpaying for NuPathe shares.
If you own NuPathe common stock and wish to obtain additional
information, please contact Joseph E. Levi,
Esq. either via email at jlevi@zlk.com or by telephone at
(212) 363-7500, toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/nupathe-path/.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
SOURCE Levi & Korsinsky, LLP